what does lincoln lawyer mean

Lincoln Lawyer is a legal thriller film directed by Brad Furman, featuring Matthew McConaughey as a criminal defense attorney who uses his office inside his car.

what does lincoln index measure

The Lincoln Index is a measure used in ecology to estimate the population density of a species by analyzing the frequency of capture and recapture in a sample.

what does lincoln lawyer streaming on

Lincoln Lawyer is available for streaming on services like Netflix, Amazon Prime Video, and YouTube TV, depending on the region and subscription.

what does lincoln financial do

Lincoln Financial Group is a financial services company that offers insurance, investments, and retirement planning services in the United States.

what does lincoln electric do

Lincoln Electric is a global manufacturing company specializing in welding equipment, automation systems, and power tools.

Lincoln Pharmaceuticals Limited (LINCOLN) Share Price Today — ₹633.95

Lincoln Pharmaceuticals Limited (LINCOLN) live stock price is ₹633.95. Listed on BSE. Sector: Healthcare. Industry: Pharmaceuticals & Biotechnology.

View Lincoln Pharmaceuticals Limited stock charts, financial results, quarterly earnings, shareholding pattern, corporate actions, peer comparison and more on Black Bear Labs.

Compare with other stocks in the Healthcare sector.

Use our Stock CAGR Calculator to calculate returns for Lincoln Pharmaceuticals Limited. Screen stocks with our Stock Screener.

Learn about key metrics: P/E Ratio, Market Cap, ROE, EPS.

LINCOLN

BSE

Lincoln Pharmaceuticals Limited

Healthcare· Pharmaceuticals & Biotechnology· INE405C01035· Scrip: 531633

EN हिन्दी ગુજરાતી मराठी

₹633.95

▲ 3.40 (+0.00%)

2026-06-10

BSE

₹633.95

▲ 3.40

+0.00%

233 trading days · 1Y period

TODAY (BSE)

Open645.95

High645.95

Low630.00

Prev Close637.35

Volume1,600

Value₹0.1Cr

L: 630.00H: 645.95

Info

Face Value₹10

Listed2015-12-17

ISININE405C01035

SeriesB

BSE Scrip531633

Key Metrics

1D

—

1W

—

1M

—

3M

—

6M

—

Valuation

P/E (TTM)—

P/E (Qtr Ann.)—

P/Sales—

Mkt Cap—

Growth (QoQ)

Revenue-9.09%

PAT-21.12%

EPS-21.14%

Profitability

EBITDA Margin27.7%

Net Margin14.2%

TTM EBITDA M.24.9%

TTM Net M.15.0%

Dividend

Yield—

Latest DPS₹1.8

Payout Ratio17.4%

Growth+0.00%

TTM Revenue

₹598 Cr

TTM EBITDA

₹149 Cr

TTM PAT

₹89 Cr

TTM EPS

₹44.62

Rev/Share

₹298.3

Quarterly Financials

Revenue

EBITDA

PAT

EPS

Quarter	Revenue	Expenses	EBITDA	PBT	PAT	EPS
2024-12-31	147 Cr	127 Cr	41 Cr	29 Cr	21 Cr	₹10.37
2024-09-30	161 Cr	136 Cr	47 Cr	35 Cr	26 Cr	₹13.15
2024-06-30	147 Cr	128 Cr	33 Cr	29 Cr	24 Cr	₹11.82
2024-03-31	142 Cr	127 Cr	29 Cr	22 Cr	19 Cr	₹9.28
2023-12-31	146 Cr	120 Cr	50 Cr	38 Cr	28 Cr	₹14.00
2023-09-30	156 Cr	128 Cr	49 Cr	37 Cr	28 Cr	₹13.81
2023-03-31	112 Cr	99 Cr	25 Cr	17 Cr	13 Cr	₹6.27
2022-12-31	134 Cr	110 Cr	42 Cr	31 Cr	22 Cr	₹10.79

Shareholding Pattern

CURRENT — 2026-03-31

Promoter49.8%

FII5.2%

DII1.1%

Public50.2%

PROMOTER HOLDING TREND

Corporate Actions

Ex-Date	Type	Purpose
2025-09-12	Dividend	Dividend - Rs 1.80 Per Share
2024-09-13	Dividend	Dividend - Rs 1.80 Per Share
2023-09-15	Dividend	Annual General Meeting/Dividend - Rs 1.50 Per Share
2022-09-15	Dividend	Annual General Meeting/Dividend - Rs 1.50 Per Share
2021-09-16	Dividend	Dividend - Rs 1.50 Per Share
2020-09-17	Other	Annual General Meeting
2020-03-05	Dividend	Interim Dividend - Rs 1.5 Per Share
2019-09-19	Dividend	Dividend - Rs 1.5 Per Share
2018-09-19	Dividend	Dividend Rs 1.50 Per Share
2017-09-21	Dividend	Annual General Meeting/Dividend - Rs 1.20 Per Share
2016-09-23	Dividend	Annual General Meeting/Dividend - Re 1/- Per Share

Price History

Date	Open	High	Low	Close	Volume
2026-06-10	635.05	643.80	628.05	633.30	38,622
2026-06-03	590.00	599.45	585.10	589.55	86,037
2026-05-27	758.60	770.00	738.30	758.15	1.24L
2026-05-26	715.10	755.00	715.10	747.45	1.03L
2026-05-25	736.00	747.00	714.10	719.15	77,560
2026-05-22	736.00	750.20	731.00	734.15	1.39L
2026-05-21	710.80	735.00	700.10	732.15	1.35L
2026-05-20	714.65	714.65	702.00	705.20	59,066
2026-05-19	691.85	723.80	690.00	710.35	2.26L
2026-05-18	633.00	694.00	621.10	678.90	1.41L
2026-05-15	661.00	665.45	641.25	644.20	39,540
2026-05-14	666.05	682.50	661.20	666.05	28,358
2026-05-13	671.10	683.00	663.15	666.05	38,378
2026-05-12	695.00	698.45	664.65	669.55	98,049
2026-05-11	694.00	724.95	690.00	699.60	2.77L
2026-05-08	668.00	683.70	660.20	674.90	46,289
2026-05-07	671.25	682.80	660.00	670.65	72,831
2026-05-06	689.80	694.60	668.10	671.30	64,453
2026-05-05	641.10	683.20	636.00	680.00	1.80L
2026-05-04	647.00	656.70	635.65	642.00	92,403
2026-04-30	664.00	678.35	642.20	645.80	2.11L
2026-04-29	654.70	733.00	653.10	673.30	36.70L
2026-04-28	622.00	648.00	610.65	646.35	1.31L
2026-04-27	605.55	624.65	600.15	622.00	57,904
2026-04-24	611.85	619.55	600.00	605.55	14,658
2026-04-23	610.00	627.90	600.00	611.45	70,551
2026-04-22	619.00	621.40	607.10	609.95	27,341
2026-04-21	624.95	634.50	603.10	608.15	58,977
2026-04-20	594.00	626.90	576.00	616.05	1.27L
2026-04-17	590.50	594.25	581.50	587.25	19,637

Frequently Asked Questions

About

Lincoln Pharmaceuticals Limited, listed on the NSE in February 2015, specializes in developing and manufacturing pharmaceutical products, with a key focus on anti-nausea medications such as its ondansetron oral spray for chemotherapy-induced nausea. The company prides itself on strong manufacturing capabilities and adherence to WHO-cGMP norms, ensuring high-quality production standards. Notably, it introduced its first proprietary product, the ondansetron oral spray, in September 2016, marking a significant milestone in its market presence.

BOARD OF DIRECTORS

Anand Arvindbhai Patel

Whole-time Director

DEPARTED

Meha Patel

Independent Director

DEPARTED

Pirabhai Suthar

Independent Director

DEPARTED

Sandra

Seema Manubhai Mehta